Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study

Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study

Objectives: To investigate effects of romosozumab treatment on disease activity and bone mineral density (BMD) in patients with rheumatoid arthritis (RA) and severe osteoporosis in comparison with effects of denosumab treatment. Methods: A total of 50 women were enrolled in this study. The subjects...

Full description

Bibliographic Details
Main Authors: Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Ken Okazaki
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Osteoporosis and Sarcopenia
Subjects:
Bone mineral density
Disease activity
Osteoporosis
Rheumatoid arthritis
Romosozumab
Online Access:http://www.sciencedirect.com/science/article/pii/S2405525521000583

Internet

http://www.sciencedirect.com/science/article/pii/S2405525521000583

Similar Items